A new COVID-19 medication has been approved in Abu Dhabi for the treatment of mild to moderate cases and those who have had direct contact with a patient.
The emirate's Department of Health (DoH) has partnered with Swiss healthcare company Roche to provide casirivimab and imdevimab to certain categories of patients.
The antibody combination has already been approved in the European Union and Japan, and conditionally approved in the UK and Australia.
It is also authorised for emergency use in the United States, India, Switzerland and Canada, and is recommended by the World Health Organisation (WHO).
.@DoHSocial has partnered with Swiss healthcare company @Roche to provide a new Covid-19 medication, approved for emergency use, to treat mild to moderate Covid-19 cases and those who have had direct contact with a positive case.
— مكتب أبوظبي الإعلامي (@ADMediaOffice) December 1, 2021
Read more: https://t.co/vGQXyUvhGB pic.twitter.com/Yj9JxVgemP
UAE allocates $8 million to support Chad amid El Nino food crisis
UAE, Syrian Presidents discuss stronger economic and development ties
Sheikha Latifa honours Arab Media Award winners
H.H. Sheikh Mohammed reaffirms 'relations with Syria' during meeting with Al-Sharaa
Abu Dhabi streamlines holiday home regulatory process
Ahmad Al-Sharaa expresses confidence in Syria's revival at Arab Media Summit
Sheikh Mansour, President of Angola discuss cooperation in phone call
UAE holds military funeral for two servicemen martyred during training
